Results 231 to 240 of about 27,184 (256)

Bictegravir/emtricitabine/tenofovir-alafenamide

Reactions Weekly, 2022
openaire   +2 more sources

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

Lancet, The, 2017
Paul E Sax, Anton L Pozniak, Andrea Antinori   +2 more
exaly  

Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial

Lancet HIV,the, 2020
Simiso Sokhela, Bryony Simmons, Michelle A Moorhouse   +2 more
exaly  

Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission

Science Translational Medicine, 2011
Nicholas J Shaheen, Angela D M Kashuba
exaly  

Tenofovir-alafenamide/tenofovir-disoproxil-fumarate

Reactions Weekly, 2018
openaire   +1 more source

The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B

Hepatology, 2017
George Papatheodoridis, Ramazan Idilman, George N Dalekos   +2 more
exaly  

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study

Lancet Infectious Diseases, The, 2016
Jose R Arribas, Matthias Cavassini, Chloe Orkin   +2 more
exaly  

Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus

Antiviral Research, 2016
Adrian S Ray, Michael Jm Hitchcock
exaly  

Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

New England Journal of Medicine, 2015
Jeanne M Marrazzo, Gonasagrie Nair, Ariane van der Straten   +2 more
exaly  

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

Journal of Hepatology, 2018
Kosh Agarwal, Young-Suk Lim, Scott Fung
exaly